4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-002957
Chief Regulatory Officer acquired 84,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schacterle Amy Chief Regulatory Officer | 2026-01-16 | Grant or award | +84,600 | 92,303 | D | ||
| Derivatives | |||||||
| Schacterle Amy Chief Regulatory Officer | 2026-01-16 | Grant or award · Employee Stock Option (right to buy) | +126,900 | 126,900 | D | ||
Loading xslF345X05/wk-form4_1769038189.xml…